BullFrog AI Holdings (BFRGW) Short-term Investments (2025)
BullFrog AI Holdings' (BFRGW) quarterly Short-term Investments came in at $100000.0 in Q4 2025, little changed quarter-over-quarter from $100000.0 in Q3 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Short-term Investments (2025) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Short-term Investments for 1 consecutive years, with $100000.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $100000.0; the trailing twelve-month figure through Dec 2025 stood at $100000.0 (changed N/A YoY), and the FY2025 full-year result was $100000.0, changed N/A from the prior year.
- Short-term Investments held at $100000.0 in Q4 2025 per BFRGW's latest filing, from $100000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $100000.0 in Q2 2025 and bottomed at $100000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.66 Bn | 197.67 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.63 Bn | 74.64 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.60 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.55 Bn | 49.41 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.71 Bn | 992.69 Mn |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |